Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-07 · 46 (7)
DOI: 10.1002/phar.70175 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 10.06.2026. Verfasst von Naheel Said und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Critical Illness, Magnesium Sulfate, Magnesium. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objective Intravenous magnesium is commonly used in critically ill patients; however, data on the serum level response following its administration are limited. This study aimed to evaluate serum magnesium changes after administration of intravenous magnesium sulfate (IV‐MgSO 4 ) and identify predictors of a greater response among critically ill patients. Methodology This retrospective multicenter study included adult critically ill patients from the Medical Information Mart for Intensive Care IV and eICU databases. Patients were included if they received IV‐MgSO 4 and had serum magnesium measured within 36 h before and after administration. Patients receiving renal replacement therapy, total parenteral nutrition, magnesium‐containing intravenous fluids, or oral magnesium supplementation were excluded. Linear regression analyses were performed to identify predictors of greater magnesium response.
Results
The study included 25,637 patients who received 54,556 doses of IV‐MgSO 4 . The mean age was 62.8 ± 16.5 Standard deviation years, and 13,180 (51.4%) were females. The most common intensive care unit admission diagnoses were cardiovascular ( n = 7399; 28.9%) and respiratory ( n = 4245; 16.6%). Baseline magnesium levels were normal in 39,149 (71.8%) episodes, mild‐to‐moderate hypomagnesemia in 13,588 (24.9%), and severe hypomagnesemia in 1819 (3.3%). Median serum magnesium increased by 0.15 mg/dL (interquartile range (IQR) 0.05–0.25) per 1 g of IV‐MgSO 4 administered, and the greatest increase was observed in patients with severe hypomagnesemia (median [IQR]: 0.25 mg/dL [0.10–0.50]), followed by mild‐to‐moderate hypomagnesemia (median [IQR]: 0.22 mg/dL [0.10–0.40]). Predictors of greater response to IV‐MgSO 4 were lower initial magnesium ( β = 0.2035; 95% confidence interval (CI): 0.193 to 0.214; p < 0.001) and reduced renal function ( β = 0.2557; 95% CI: 0.212 to 0.300; p < 0.001).
Conclusion
Among a large cohort of critically ill patients, 1 g of IV‐MgSO 4 was associated with a median serum magnesium increase of 0.15 mg/dL. Lower initial magnesium and reduced renal function were predictors of greater serum magnesium increase with intravenous replacement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
- Dalle Molle Institute for Artificial Intelligence, University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina, USA.
- Division of Translational Biomedical Informatics, Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Naheel Said, Wedad Awad, Asma'a Al-Kharabsheh, An-Kwok Ian Wong, Lama Nazer
Zitieren
APA
Said, N., Angelotti, G., Awad, W., Al-Kharabsheh, A., Wong, A. I., & Nazer, L. (2026). Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(7). https://doi.org/10.1002/phar.70175
Vancouver
Said N, Angelotti G, Awad W, Al-Kharabsheh A, Wong AI, Nazer L. Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(7). doi:10.1002/phar.70175
BibTeX
@article{Said2026,
author = {Said, Naheel and Angelotti, Giovani and Awad, Wedad and Al-Kharabsheh, Asma'a and Wong, An-Kwok Ian and Nazer, Lama},
title = {Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2026},
volume = {46},
number = {7},
doi = {10.1002/phar.70175}
}
EUVIMED